IO Biotech's total assets for Q2 2025 were $42.33M, a decrease of -7.46% from the previous quarter. IOBT total liabilities were $40.73M for the fiscal quarter, a 110.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.